Please try another search
Dantax A/S reported earnings results for the first quarter ended September 30, 2023. For the first quarter, the company reported sales was DKK 8.2 million compared to DKK 5.36 million a year ago. Revenue was DKK 8.32 million compared to DKK 5.46 million a year ago. Net income was DKK 1.48 million compared to net loss of DKK 3.08 million a year ago. Basic earnings per share from continuing operations was DKK 5 compared to basic loss per share from continuing operations of DKK 10.4 a year ago. Diluted earnings per share from continuing operations was DKK 4.9.
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Revenue | 7.31 | 8.2 | 6.54 | 4.72 |
Gross Profit | 2.31 | 2.31 | 3.54 | 1.49 |
Operating Income | 0.516 | 0.934 | 2.07 | -0.176 |
Net Income | 2.52 | 1.48 | 2.78 | 5.05 |
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Assets | 79.28 | 78.7 | 77.32 | 74.03 |
Total Liabilities | 7.93 | 6.27 | 5.9 | 5.45 |
Total Equity | 71.35 | 72.43 | 71.42 | 68.58 |
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | 0.664 | 2.89 | -0.603 | -0.379 |
Cash From Investing Activities | 1.42 | -1.63 | 1.11 | 2.3 |
Cash From Financing Activities | -3.72 | 0.606 | 0.456 | 0.013 |
Net Change in Cash | -1.63 | 1.87 | 0.961 | 1.93 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review